Short-term evaluation of autologous transplantation of bone marrow-derived mesenchymal stem cells in patients with cirrhosis: Egyptian study

Clinical Transplantation

Volumn 27, Issue 4, 2013, Pages 607-612

  Amin, Mona A ^a   Sabry, Dina ^a   Rashed, Laila A ^a   Aref, Wael M ^a   el Ghobary, Mohamed Ahmed ^a   Farhan, Marwa Salah ^a   Fouad, Hany Ahmed ^a   Youssef, Youssef Abdel Aziz ^b  

^a CAIRO UNIVERSITY   (Egypt)

^b AL AZHAR UNIVERSITY   (Egypt)

Author keywords

Egypt; Human; Intrasplenic injection liver cirrhosis patients; Mesenchymal stem cells

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; SODIUM CHLORIDE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BILIRUBIN BLOOD LEVEL; CELL ISOLATION; CLINICAL ARTICLE; CLINICAL EVALUATION; ECHOGRAPHY; EGYPT; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HEPATITIS C; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERNATIONAL NORMALIZED RATIO; LIVER CIRRHOSIS; LIVER FUNCTION; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; PATIENT SAFETY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTHROMBIN TIME; SPLEEN; STATISTICAL SIGNIFICANCE;

EGYPT; HUMAN; INTRASPLENIC INJECTION - LIVER CIRRHOSIS PATIENTS; MESENCHYMAL STEM CELLS;

ADULT; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; BONE MARROW; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIVER CIRRHOSIS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; STROMAL CELLS; TRANSPLANTATION, AUTOLOGOUS;

EID: 84881489447     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/ctr.12179     Document Type: Article

References (24)

1. Forbes SJ, Russo FP, Rey V et al. A significant proportion of myofibroblasts are of bone marrow origin in human liver fibrosis. Gastroenterology 2004: 126: 955.
2. Yang L, Jung Y, Omenetti A. Fate-mapping evidence that hepatic stellate cells are epithelial progenitors in adult mouse livers. Stem Cells 2008: 26: 2104.
3. +stem/progenitor cell transplantation in rats. Int J Stem Cells 2010: 3: 2.
4. Salama H, Zekri AR, Zern M et al. Autologous hematopoietic stem cell transplantation in 48 patients with end-stage chronic liver diseases. Cell Transplant 2010: 19: 1475.
5. Kallis YN, Alison MR, Forbes SJ. Bone marrow stem cells and liver disease. Gut 2007: 56: 716.
6. Abdel Aziz MT, Atta HM, Mahfouz S et al. Therapeutic potential of bone marrow-derived mesenchymal stem cells on experimental liver fibrosis. Clin Biochem 2007: 40: 893.
7. El-Ansary M, Abdel-Aziz I, Mogawer S et al. Phase II trial: undifferentiated versus differentiated autologous mesenchymal stem cells transplantation in Egyptian patients with HCV induced liver cirrhosis. Stem Cell Review 2012: 8: 972.
8. Am Esch JS II, Knoefel WT, Klein M et al. Portal application of 13. autologous CD133 + bone marrow cells to the liver: a novel concept to support hepatic regeneration. Stem Cells 2005: 23: 463.
9. Terai S, Sakaida I, Yamamoto N et al. An in vivo model for monitoring 14. Trans-differentiation of bone marrow cells into functional hepatocytes. J Biochem (Tokyo) 2003: 134: 551.
10. Terai S, Ishikawa T, Omori K et al. Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy. Stem Cells 2006: 24: 2292.
11. Haleem AM, Singergy AA, Sabry D et al. The clinical use of human culture-expanded autologous bone marrow mesenchymal stem cells transplanted on platelet-rich fibrin glue in the treatment of articular cartilage defects: a pilot study and preliminary results. Cartilage 2010: 1: 253.
12. Mokbel AN, El Tookhy OS, Shamaa AA, Rashed LA, Sabry D, El Sayed AM. Homing and reparative effect of intra-articular injection of autologus mesenchymal stem cells in osteoarthritic animal model. BMC Musculoskelet Disord 2011: 12: 259.
13. Abdel Aziz MT, El Asmar MF, Atta HM et al. Efficacy of mesenchymal stem cells in suppression of hepatocarcinorigenesis in rats: possible role of Wnt signaling. Exp Clin Cancer Res 2011: 30: 49.
14. Rochefort GY, Vaudin P, Bonnet N et al. Influence of hypoxia on the domiciliation of mesenchymal stem cells after infusion into rats: possibilities of targeting pulmonary artery remodeling via cells therapies? Respir Res 2005: 6: 125.
15. Mohamadnejad M, Alimoghaddam K, Mohyeddin-Bonab M et al. Phase 1 trial of autologous bone marrow mesenchymal stem cell transplantation in patients with decompensated liver cirrhosis. Arch Iran Med 2007: 10: 459. Erratum in: Arch Iran Med 2008: 11: 135.
16. Pai M, Spalding D, Xi F, Habib N. Autologous bone marrow stem cells in the treatment of chronic liver disease. Int J Hepatol 2012: 2012: 307165.
17. Petersen BE, Bowen WC, Patrene KD et al. Bone marrow as a potential source of hepatic oval cells. Science 1999: 284: 1168.
18. Alison MR, Poulsom R, Jeffery R et al. Hepatocytes from non-hepatic adult stem cells. Nature 2000: 406: 257.
19. Zhang B, Inagaki M, Jiang B et al. Effects of BM and hepatocyte transplantation on liver injury. J Surg Res 2009: 157: 71.
20. Van Poll D, Parekkadan B, Cho CH et al. Mesenchymal stem cell-derived molecules directly modulate hepatocellular death and regeneration in vitro and in vivo. Hepatology 2008: 47: 1634.
21. Terai S, Ishikawa T, Omori K et al. Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy. Stem Cells 2006: 24: 2292.
22. Gordon MY, Levicar N, Pai M et al. Characterisation and clinical application of human CD34 + stem/progenitor cell populations mobilized into the blood by granulocyte colony-stimulating factor. Stem Cells 2006: 24: 1822.
23. Sakaida I, Terai S, Yamamoto N et al. Transplantation of bone marrow cells reduces CCl4-induced liver fibrosis in mice. Hepatology 2004: 40: 1304.
24. Mohamadnejad M, Alimoghaddam K, Mohyeddin-Bonab M et al. Phase 1 trial of autologous bone marrow mesenchymal stem cell transplantation in patients with decompensated liver cirrhosis. Arch Iran Med 2007: 10: 459.